Chem Rev 96:25632605
Diagnosis Doctors review your symptoms, diet, and medical history to look for possible signs of vitamin B12 deficiency
Jurkovicova D, Neophytou CM, Gaparovi A, Gonalves AC
By Type The GLP-1 receptor agonist market is segmented by drug class into: a) Liraglutide b) Semaglutide c) Tirzepatide d) Dulaglutide e) Other Drugs By Route Of Administration The GLP-1 receptor agonist market is segmented by route of administration into: a) Parenteral b) Oral By End-User The GLP-1 receptor agonist market is segmented by end-user into: a) Hospitals b) Surgical Clinics c) Other End-Users By Geography - The GLP-1 receptor agonist market is segmented by geography into: China India Japan Australia Indonesia South Korea USA Canada Brazil France Germany UK Italy Spain Russia o Asia Pacific o Africa GLP-1 Receptor Agonist Market Drivers The key drivers of the GLP-1 receptor agonist market include: Rise In Obesity Rates During the forecast period, the rise in obesity rates will propel the growth of the GLP-1 receptor agonist market
meanwhile, LEADER reported a potential association between the use of GLP-1 RAs and pancreatitis and pancreatic cancer, so it is not practical to treat every T2DM patients with these two drugs
doi: 10.1038/s41419-023-05963-1, 125 VandenabeeleP.GalluzziL.VandenB
